Predictive Oncology Inc reports results for the quarter ended September 30 - Earnings Summary

Axe Compute

13/11/2024 14:17

* Predictive Oncology Inc  POAI.OQ  reported a quarterly
adjusted
loss of 48 cents​​ per share for the quarter ended September
30.  The lone analyst forecast for the quarter was for a loss
of 32 cents per share. 
    * Revenue was $346.00 thousand​; analysts expected $500.00
thousand. 
    * Predictive Oncology Inc's reported EPS for the quarter was
a
loss of 48 cents​.
    * Predictive Oncology Inc shares had fallen by 0.1% this
quarter and lost 76.1% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Predictive
Oncology Inc is $3.00 
This summary was machine generated from LSEG data November 13 at
02:17 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.32          -0.48          Missed